Impact of Covid-19 Pandemic on Financial Performance in Sub-Sector Pharmaceutical Companies Listed on the IDX

Authors

  • Agung Zulfikri Nusa Putra University, West Java, Indonesia
  • Tera Lesmana Nusa Putra University, West Java, Indonesia
  • Gustian Djuanda Nusa Putra University, West Java, Indonesia

DOI:

https://doi.org/10.11594/nstp.2021.1016

Keywords:

EPS (Earning Per Share), ROE (Return On Equity), profitability ratio

Abstract

This study aims to analyze the effect of companies' financial performance amid a pandemic in pharmaceutical companies listed on the IDX. This study uses the financial ratios of EPS and ROE as independent variables. The results show that EPS and ROE positively affect stock prices, which means that each increase in EPS and ROE will increase stock prices. To increase stock prices, companies should make efficient and increase ROE. This study's objects are three companies, namely sub-companies—the pharmaceutical sector on the IDX for the period 2018 to 2020. The results of this study, EPS, and ROE do not affect share prices simultaneously.

Downloads

Download data is not yet available.

Downloads

Published

18-06-2021

How to Cite

Zulfikri, A. ., Lesmana, T. ., & Djuanda, G. . (2021). Impact of Covid-19 Pandemic on Financial Performance in Sub-Sector Pharmaceutical Companies Listed on the IDX. Nusantara Science and Technology Proceedings, 4(4), 138-144. https://doi.org/10.11594/nstp.2021.1016

Similar Articles

1-10 of 233

You may also start an advanced similarity search for this article.